Skip to content

Clinical trials

Phase 1/2 Reperfusion Injury trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reperfusion Injury Phase: Phase 1/2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20154
20161
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2
Active, not recruiting1
Recruiting1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital, Sun Yat-Sen University2
Capital Medical University1
Rhode Island Hospital1
Shengjing Hospital1
Stealth BioTherapeutics Inc.1
Tomsk National Research Medical Center of the Russian Academy of Sciences1
University of Pennsylvania1
Xijing Hospital1
iCoat Medical AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reperfusion Injury10
Delayed Graft Function2
Kidney Tubular Necrosis, Acute2
Coronary Artery Disease1
Hypertension, Renovascular1
Ischemia1
Ischemic Stroke1
Myocardial Reperfusion Injury1
Renal Artery Obstruction1
Spinal Cord Injuries1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.